EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ferroptosis in Pneumoconiosis: From Molecular and Cellular Mechanisms to Therapeutic Strategies

Mengli Yan, Jing Zhang, Gaili Ji, Xiaobin Fang, Chunheng Mo

Med Research · 2025-09 · 1 (2) · 239-256

DOI: 10.1002/mdr2.70020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Med Research, online erschienen am 21.07.2025. Verfasst von Mengli Yan und 4 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, Science and Technology Department of Henan Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pneumoconiosis, caused by exposure to inorganic hazardous materials, is a highly prevalent and severe occupational disease. It is characterized by a progressive inflammatory process and the development of permanent lung fibrosis, which ultimately can lead to respiratory failure and mortality. Ferroptosis is a non‐apoptotic, regulated cell death pathway driven by iron‐of dependent accumulation membrane‐localized lipid peroxides. It acts as a promoting mechanism and participates in the biological processes of pneumoconiosis. Notably, alveolar macrophages, epithelial cells, and endothelial cells exhibit exquisite vulnerability to ferroptosis, highlighting targeting this process as a promising treatment approach for pneumoconiosis. Thus, a comprehensive and in‐depth understanding of the role of ferroptosis in pneumoconiosis is critical to enable the successful clinical translation of ferroptosis‐targeted therapies. In this review, we provide an overview of the recent advancements in understanding ferroptosis in pneumoconiosis, covering molecular mechanisms, regulatory pathways and biological functions. We also summarize the potential applications of ferroptosis inhibition for pneumoconiosis treatment across pulmonary cell populations. We finally discuss the current challenges and future directions of ferroptosis in the treatment of pneumoconiosis.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province
  • Science and Technology Department of Henan Province
  • Ningxia Medical University

Zitieren

APA

Yan, M., Zhang, J., Ji, G., Fang, X., & Mo, C. (2025). Ferroptosis in Pneumoconiosis: From Molecular and Cellular Mechanisms to Therapeutic Strategies. Med Research, 1(2), 239-256. https://doi.org/10.1002/mdr2.70020

Vancouver

Yan M, Zhang J, Ji G, Fang X, Mo C. Ferroptosis in Pneumoconiosis: From Molecular and Cellular Mechanisms to Therapeutic Strategies. Med Research. 2025;1(2):239-256. doi:10.1002/mdr2.70020

BibTeX
@article{Yan2025,
  author = {Yan, Mengli and Zhang, Jing and Ji, Gaili and Fang, Xiaobin and Mo, Chunheng},
  title = {Ferroptosis in Pneumoconiosis: From Molecular and Cellular Mechanisms to Therapeutic Strategies},
  journal = {Med Research},
  year = {2025},
  volume = {1},
  number = {2},
  pages = {239--256},
  doi = {10.1002/mdr2.70020}
}
Kostenlos starten →